Luke Walker

Insider Reports History

Entity: Individual
Location: C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA
Signature: /s/ Andrea Paul, attorney-in-fact for Luke Walker
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Luke Walker:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Zentalis Pharmaceuticals, Inc.	Director	Common Stock	86.7K	$152K	$1.76	Jan 31, 2025	Direct
Harpoon Therapeutics, Inc.	Chief Medical Officer	Common Stock	0	$0	$23.00	Mar 11, 2024	Direct
Context Therapeutics Inc.	Director	Stock Option (right to buy)	19.3K			Sep 4, 2024	Direct
Harpoon Therapeutics, Inc.	Chief Medical Officer	Employee Stock Option (Right to Buy)	0			Mar 11, 2024	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Luke Walker

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ZNTL	Zentalis Pharmaceuticals, Inc.	Jan 31, 2025	1	$25K	4	Feb 4, 2025	Director
CNTX	Context Therapeutics Inc.	Sep 4, 2024	1	$0	4	Sep 5, 2024	Director
CNTX	Context Therapeutics Inc.	Sep 4, 2024	0	$0	3	Sep 5, 2024	Director
ZNTL	Zentalis Pharmaceuticals, Inc.	May 24, 2024	1	$0	4	May 29, 2024	Director
ZNTL	Zentalis Pharmaceuticals, Inc.	May 24, 2024	0	$0	3	May 29, 2024	Director
HARP	Harpoon Therapeutics, Inc.	Mar 11, 2024	3	$0	4	Mar 11, 2024	Chief Medical Officer
HARP	Harpoon Therapeutics, Inc.	Jan 7, 2024	1	$0	4	Jan 9, 2024	Chief Medical Officer
HARP	Harpoon Therapeutics, Inc.	Nov 26, 2023	1	$0	4	Nov 28, 2023	Chief Medical Officer
HARP	Harpoon Therapeutics, Inc.	Jan 24, 2023	1	$0	4	Jan 26, 2023	Chief Medical Officer
HARP	Harpoon Therapeutics, Inc.	Oct 3, 2022	1	$0	4	Oct 4, 2022	Chief Medical Officer
HARP	Harpoon Therapeutics, Inc.	Oct 3, 2022	0	$0	3	Oct 4, 2022	Chief Medical Officer